CB vs EYPT · P/E 14, rev $59.40B vs rev $43.3M
Chubb Ltd (CB) versus Eyepoint Pharmaceuticals Inc (EYPT) — a side-by-side from cached financials, not a winner call.
Chubb Ltd (CB) is a insurance - property & casualty company listed on US.
Eyepoint Pharmaceuticals Inc (EYPT) is a biotechnology company listed on NASDAQ.
Latest reported CB revenue for 2025-12-31 was $59.40B. Net income was $10.31B. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. CB currently screens at market cap $114.26B and trailing P/E 13.7.
Latest reported EYPT revenue for 2024-12-31 was $43.3M. Net income was -$130.9M. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. EYPT currently screens at market cap $1.10B.
CB currently screens at market cap $114.26B and trailing P/E 13.7. EYPT currently screens at market cap $1.10B.
Not investment advice. Open the CB and EYPT stock pages for the full models.
Not investment advice.